Clinical Trials Directory

Trials / Completed

CompletedNCT05919628

Psychological Ressources, Anxiodepressive Symptoms, Well-being and Therapeutical Observance in Parkinson's Disease

Psychological Ressources as a Protective Factor for Anxiety-depression, Well-being and Therapeutical Observance in Parkinson's Disease.

Status
Completed
Phase
Study type
Observational
Enrollment
25 (actual)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Anxiodepressive symptoms are frequently observed in Parkinson's disease patients. These non motor psychiatric charateristics of the disease negatively impairs quality of life, and may impair well-being or therapeutical observance. The objective of this study is to determine if psychological ressources are associated to anxiodepressive symptoms, to parkinson well-being and therapeutical observance. It will be interesting to determine if the presence of some - or multiple- psychological ressources could prevent patients from anxiety, depression, impaired well-being and impaired observance. This study will analyse retrospectively psychological scalescompleted by 30 parkinson's disease patients through previous psychological interviews. The scales investigate anxiety, depression, well-being, psychological ressources, and therapeutical observance. The results will highlight the importance of working on psychological ressources with Parkinson's disease patients through psychotherapy, in order to improve their well-being, positive emotions and maybe contribute to better therapeutical observance.

Detailed description

The scales used are : * The SPANE * The PAS * The LOT-R * The SCS * The brief BDI * The SSAM * The HAD * The MAAS * An observance scale

Conditions

Interventions

TypeNameDescription
OTHERResPsyPark groupEvaluation of the parkinson's disease patient's score over different psychological questionnaires and a therapeutical observance questionnaire

Timeline

Start date
2023-06-15
Primary completion
2023-06-15
Completion
2023-06-30
First posted
2023-06-26
Last updated
2023-09-06

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05919628. Inclusion in this directory is not an endorsement.